Which vaccines are approved in the US for the prevention of community-acquired pneumonia (CAP)?

Updated: Oct 31, 2019
  • Author: Stephanie L Baer, MD; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print


Two pneumococcal vaccines are approved in the United States; 13-valent polysaccharide conjugate vaccine (PCV13; Prevnar 13) is approved for children aged 6 weeks to 17 years and adults aged 50 years or older. The 23-valent pneumococcal polysaccharide vaccine (PPSV23; Pneumovax 23) is approved for adults aged 65 years or older and persons aged 2 years or older who are at an increased risk for pneumococcal disease.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!